SEARCH HEALTH CONDITIONS BY ALPHABETS
Microsporidiosis
Medications for Microsporidiosis
About Microsporidiosis: An autoimmune disease which causes diarrhoea and wasting in people who have HIV. It results from two species of microsporidia, a parasite.
Drugs Used to Heal Microsporidiosis
This listing of medications come somehow associated with, or utilized in the treatment of this condition.
| Medication name | Rx / OTC | Pregnancy | CSA | Alcohol | Reviews | Rating | Popularity |
|---|---|---|---|---|---|---|---|
| itraconazole | Rx | C | N | Add inspection | 0.0 | ||
Generic title: itraconazole systemic Brand names: Sporanox, Onmel Medication class: azole antifungals For users: dose, interactions, For professionals: a Z Drug Truth, AHFS DI Monograph, Prescribing Information | |||||||
| albendazole | Rx | C | N | Add inspection | 0.0 | ||
Generic title: albendazole systemic Brand title: Albenza Medication class: anthelmintics For users: dose, interactions, For professionals: a Z Drug Truth, AHFS DI Monograph, Prescribing Information | |||||||
| Albenza | Rx | C | N | Add inspection | 0.0 | ||
Generic title: albendazole systemic Medication class: anthelmintics For users: dose, interactions, and side effects For professionals: AHFS DI Monograph, Prescribing Information | |||||||
| Sporanox | Rx | C | N | Add inspection | 0.0 | ||
Generic title: itraconazole systemic Medication class: azole antifungals For users: dose, interactions, and side effects For professionals: AHFS DI Monograph, Prescribing Information | |||||||
| Onmel | Rx | C | N | Add inspection | 0.0 | ||
Generic title: itraconazole systemic Medication class: azole antifungals For users: dose, interactions, and side effects For professionals: Prescribing Information | |||||||
Legend
| Rx | Prescription Only |
|---|---|
| OTC | On The Counter |
| Rx/OTC | Prescription or Over the Counter |
| Off Label | This drug may not be approved by the FDA for the treatment of this condition. |
| Pregnancy Category | |
|---|---|
| A | Adequate and well-controlled studies have failed to present a risk to the embryo within the first trimester of pregnancy (also there is no evidence of risk in later trimesters). |
| B | Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women. |
| C | Animal reproduction studies have shown an adverse effect in the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks. |
| D | there was positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use in pregnant women despite potential risks. |
| X | Studies in animals or humans have demonstrated fetal abnormalities or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and also the risks entailed in use in pregnant women clearly outweigh potential rewards. |
| N | FDA have not classified the drug. |
| Controlled Substances Act (CSA) Program | |
|---|---|
| N | Is not at the mercy of the Controlled Substances Act. |
| Inch | features a high possibility of abuse. Has no currently accepted medical use in treatment in the United States. There is just a lack of accepted safety for use under medical supervision. |
| Two | features a high possibility of abuse. Features a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may result in severe psychological or physical dependency. |
| 3 | features a possibility for abuse less than people in programs 1 and 2. Features a currently accepted medical use in treatment in the United States. Abuse may lead to physical dependence or high psychological dependence. |
| 4 | features a very low potential for abuse relative to people in schedule 3. It`s a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to people in schedule 3. |
| 5 | features a very low potential for abuse relative to people in schedule 4. Features a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence. |
| Alcohol | |
|---|---|
| X | Interacts with Alcohol. |
Browse Treatment Options
- A
- B
- C
- D
- E
- F
- G
- H
- that I
- J
- K
- L
- M
- N
- O
- P
- Q
- Dtc
- S
- T
- U
- V
- W
- X
- Y
- Z
Further info
Always ask your healthcare provider to make sure the information displayed on this page relates to your circumstances.
Top USA Pharma Companies
Popular Categories
Easily find an affordable health insurance plan
